Detalles de la búsqueda
1.
Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate.
Eur Child Adolesc Psychiatry
; 25(2): 141-9, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25999292
2.
Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.
BMC Psychiatry
; 13: 39, 2013 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-23356790
3.
Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.
N Engl J Med
; 354(1): 23-33, 2006 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-16394299
4.
Sex subgroup analysis of treatment response to lisdexamfetamine dimesylate in children aged 6 to 12 years with attention-deficit/hyperactivity disorder.
J Clin Psychopharmacol
; 32(1): 138-40, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22217951
5.
Treatment With Lisdexamfetamine Dimesylate Improves Self- and Informant-Rated Executive Function Behaviors and Clinician- and Informant-Rated ADHD Symptoms in Adults: Data From a Randomized, Double-Blind, Placebo-Controlled Study.
J Atten Disord
; 21(14): 1198-1207, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24464328
6.
ADHD Symptom Rebound and Emotional Lability With Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years.
J Atten Disord
; 21(1): 52-61, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23407278
7.
Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults.
Int J Antimicrob Agents
; 20(3): 165-73, 2002 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12385694
8.
Relationship of ADHD symptoms and global illness severity in adults treated with lisdexamfetamine dimesylate.
Postgrad Med
; 126(5): 31-41, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25295648
9.
Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial.
Neuropsychiatr Dis Treat
; 10: 2039-47, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25378930
10.
The effects of lisdexamfetamine dimesylate on emotional lability in children 6 to 12 years of age with ADHD in a double-blind placebo-controlled trial.
J Atten Disord
; 18(2): 123-32, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22740112
11.
Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder.
CNS Drugs
; 28(12): 1191-203, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25139785
12.
Treatment response and remission in a double-blind, randomized, head-to-head study of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit hyperactivity disorder.
CNS Drugs
; 28(11): 1059-69, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25038977
13.
Treatment outcomes with lisdexamfetamine dimesylate in children who have attention-deficit/hyperactivity disorder with emotional control impairments.
J Child Adolesc Psychopharmacol
; 23(6): 386-93, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23952185
14.
Parent-reported executive function behaviors and clinician ratings of attention-deficit/hyperactivity disorder symptoms in children treated with lisdexamfetamine dimesylate.
J Child Adolesc Psychopharmacol
; 23(1): 28-35, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23410139
15.
Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults.
Neuropsychiatr Dis Treat
; 9: 219-29, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23431065
16.
Efficacy and safety of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder and recent methylphenidate use.
Adv Ther
; 30(5): 472-86, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23681505
17.
Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorder.
CNS Drugs
; 27(10): 829-40, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23893527
18.
Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study.
BMC Pharmacol Toxicol
; 13: 18, 2012 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-23254273
19.
Attention deficit hyperactivity disorder subtypes and symptom response in adults treated with lisdexamfetamine dimesylate.
Innov Clin Neurosci
; 9(5-6): 22-30, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22808446
20.
Clinically relevant changes in emotional expression in children with ADHD treated with lisdexamfetamine dimesylate.
J Atten Disord
; 16(5): 384-97, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21173426